April 2017 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for April 2017. This roundup includes...
Older Women Show Limited Understanding of Osteoporosis
Even after an osteoporosis-related fracture, few women are on pharmacotherapy
Exercise Reduces Weight Gain Effects in Those With FTO Gene
No evidence for interaction with physical activity for loci other than established FTO locus
Routine Blood Tests Can Harm Patient Care
Authors of opinion piece say unnecessary lab tests contribute to rising costs, can damage patient care
Algorithm Integrated Into App Forecasts Glucose Levels
Method using Gaussian process models produces personalized, nutrition-based forecast
Meeting Organizers Overlooking Qualified Female Scientists
Active generation of lists of potential speakers, assessment of qualifications can address bias
Risk Factors in Six Areas Tied to Physician Burnout
Tool gauging burnout focuses on workload, control, rewards, community, fairness, values
Three Anti-VEGF Treatments Effective for Diabetic Retinopathy
Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab
Single-Payer Health System Bill Moves Forward in California
Not yet clear where money for the single-payer system would come from
Plasma Uric Acid Lowering Tied to Drop in Systolic BP in T1DM
Febuxostat has modest BP-lowering effect, with no impact on arterial stiffness, urinary nitric oxide
